Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

40.87
-1.1600-2.76%
Post-market: 40.870.00000.00%19:30 EDT
Volume:1.00M
Turnover:41.20M
Market Cap:3.29B
PE:29.31
High:42.66
Open:42.61
Low:40.79
Close:42.03
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:1.02
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.37
PE(LYR):49.84

Loading ...

Veracyte Inc : Jefferies Raises Target Price to $70 from $48

THOMSON REUTERS
·
Jul 06

Veracyte is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 29

Veracyte director Karin Eastham disposes of 3,729 common shares worth $197,478.18

Reuters
·
Jun 23

Veracyte (VCYT) Stock Could Be 4.5% Overvalued After Its Recent Run

Simply Wall St.
·
Jun 19

Veracyte shareholders endorse board, pay and incentive plans

TIPRANKS
·
Jun 12

Veracyte shareholders approve 3.5 million-share increase to 2023 equity plan at annual meeting

Reuters
·
Jun 12

Veracyte EVP, General Counsel Annie McGuire disposes of common shares worth $159,490

Reuters
·
Jun 05

Veracyte CFO Rebecca Chambers disposes of 3,561 common shares worth $177,866.63

Reuters
·
Jun 05

Veracyte CEO Marc Stapley disposes of common shares worth $7.35 million

Reuters
·
Jun 05

Veracyte Global Chief Commercial Officer John Leite disposes of USD 700,732 in common shares

Reuters
·
Jun 05

Veracyte posts investor presentation outlining growth strategy for genomic cancer diagnostics portfolio

Reuters
·
Jun 03

Needham Raises Price Target on Veracyte to $57 From $48, Keeps Buy Rating

MT Newswires Live
·
Jun 02

Veracyte assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

Veracyte Is Maintained at Buy by Needham

Dow Jones
·
Jun 01

Veracyte Inc : Needham Raises Target Price to $57 From $48

THOMSON REUTERS
·
Jun 01

Veracyte posts investor presentation on ASCO findings

Reuters
·
Jun 01

Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting

TIPRANKS
·
May 31

Veracyte - Enzamet Trial Shows Decipher Prostate Test Identifies Chemotherapy Benefit in Metastatic Prostate Cancer

THOMSON REUTERS
·
May 30

Veracyte says ENZAMET trial shows Decipher Prostate test flags metastatic patients who benefit from adding docetaxel

Reuters
·
May 30

Veracyte Says Prosigna Test Can Help High-Risk Breast Cancer Patients Avoid Chemotherapy

MT Newswires Live
·
May 30